Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

241 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Abnormal Pretreatment Liver Function Tests Are Associated with Discontinuation of Peptide Receptor Radionuclide Therapy in a U.S.-Based Neuroendocrine Tumor Cohort.
Heckert JM, Kipnis ST, Kumar S, Botterbusch S, Alderson A, Bennett B, Creamer C, Eads JR, Soulen MC, Pryma DA, Mankoff DA, Metz DC, Katona BW. Heckert JM, et al. Among authors: metz dc. Oncologist. 2020 Jul;25(7):572-578. doi: 10.1634/theoncologist.2019-0743. Epub 2020 Mar 6. Oncologist. 2020. PMID: 32141667 Free PMC article.
Efficacy of Peptide Receptor Radionuclide Therapy in a United States-Based Cohort of Metastatic Neuroendocrine Tumor Patients: Single-Institution Retrospective Analysis.
Katona BW, Roccaro GA, Soulen MC, Yang YX, Bennett BJ, Riff BP, Glynn RA, Wild D, Nicolas GP, Pryma DA, Teitelbaum UR, Metz DC. Katona BW, et al. Among authors: metz dc. Pancreas. 2017 Oct;46(9):1121-1126. doi: 10.1097/MPA.0000000000000919. Pancreas. 2017. PMID: 28902781 Free PMC article.
Laboratory, Clinical, and Survival Outcomes Associated With Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors.
Kipnis ST, Hung M, Kumar S, Heckert JM, Lee H, Bennett B, Soulen MC, Pryma DA, Mankoff DA, Metz DC, Eads JR, Katona BW. Kipnis ST, et al. Among authors: metz dc. JAMA Netw Open. 2021 Mar 1;4(3):e212274. doi: 10.1001/jamanetworkopen.2021.2274. JAMA Netw Open. 2021. PMID: 33755166 Free PMC article.
NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy.
Hope TA, Bodei L, Chan JA, El-Haddad G, Fidelman N, Kunz PL, Mailman J, Menda Y, Metz DC, Mittra ES, Pryma DA, Reidy-Lagunes DL, Singh S, Strosberg JR. Hope TA, et al. Among authors: metz dc. J Nucl Med. 2020 Feb;61(2):222-227. doi: 10.2967/jnumed.119.240911. J Nucl Med. 2020. PMID: 32015164 Free PMC article. No abstract available.
Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival.
Chen JX, Rose S, White SB, El-Haddad G, Fidelman N, Yarmohammadi H, Hwang W, Sze DY, Kothary N, Stashek K, Wileyto EP, Salem R, Metz DC, Soulen MC. Chen JX, et al. Among authors: metz dc. Cardiovasc Intervent Radiol. 2017 Jan;40(1):69-80. doi: 10.1007/s00270-016-1478-z. Epub 2016 Oct 13. Cardiovasc Intervent Radiol. 2017. PMID: 27738818
Differential Diagnosis of Diarrhea in Patients With Neuroendocrine Tumors.
Eads JR, Reidy-Lagunes D, Soares HP, Chan JA, Anthony LB, Halfdanarson TR, Naraev BG, Wolin EM, Halperin DM, Li D, Pommier RF, Zacks JS, Morse MA, Metz DC; from the Carcinoid Syndrome Control Collaborative. Eads JR, et al. Among authors: metz dc. Pancreas. 2020 Oct;49(9):1123-1130. doi: 10.1097/MPA.0000000000001658. Pancreas. 2020. PMID: 32991344 Review.
Presacral neuroendocrine tumors associated with the Currarino syndrome.
Scott AT, Tessmann JB, Braun T, Brown B, Breheny PJ, Darbro BW, Bellizzi AM, Dillon JS, O'Dorisio TM, Alderson A, Bennett B, Bernat JA, Metz DC, Howe JR. Scott AT, et al. Among authors: metz dc. Am J Med Genet A. 2021 May;185(5):1582-1588. doi: 10.1002/ajmg.a.62145. Epub 2021 Mar 1. Am J Med Genet A. 2021. PMID: 33650152
241 results